South Korea Gene Therapy Market

ID: MRFR/Pharma/51498-HCR

200 Pages

Rahul Gotadki

September 2025

South Korea Gene Therapy Market Research Report By Therapeutic Area (Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders), By Technology (Viral Vectors, CRISPR, Gene Editing, RNA Therapy, Non-Viral Methods), By Application (Research, Clinical, Commercial) and By Route of Administration (Intravenous, Intramuscular, Intradermal, Intrathecal, Oral)- Forecast to 2035

South Korea Gene Therapy Market Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

South Korea Gene Therapy Market Summary

The South Korea Gene Therapy market is projected to grow significantly from 129 USD Million in 2024 to 612 USD Million by 2035.

Key Market Trends & Highlights

South Korea Gene Therapy Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 15.2% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 612 USD Million, indicating robust growth potential.
In 2024, the market is valued at 129 USD Million, reflecting the current investment landscape in gene therapy.
Growing adoption of innovative therapies due to increasing prevalence of genetic disorders is a major market driver.

South Korea Gene Therapy Market

CAGR

15.2%

Market Size & Forecast

2024 Market Size	129 (USD Million)
2035 Market Size	612 (USD Million)
CAGR (2025-2035)	15.2%

Major Players

Amgen, Genethon, Bluebird Bio, BristolMyers Squibb, Sangamo Therapeutics, Genzyme, Samsung Biologics, Roche, GSK, Medgene, Spark Therapeutics, Hana Biosciences, LG Chem, Novartis, AbbVie

South Korea Gene Therapy Market Trends

The South Korea gene therapy market is witnessing significant growth driven by several key market drivers. One of the primary factors is the country's robust focus on biotechnology and medical research, which has led to substantial investments in innovative treatments. The South Korean government has launched initiatives to promote the development and commercialization of gene therapies, aiming to enhance healthcare outcomes while establishing the region as a leader in biopharmaceutical technology.

Moreover, the rising prevalence of genetic disorders and chronic diseases is increasing the demand for advanced therapeutic options, highlighting the urgency for effective gene therapies.There are numerous opportunities to be explored in the South Korea gene therapy market. The government’s support for local biotech companies through funding programs and incentives encourages collaboration between research institutions and private entities. This collaboration is fostering an environment where new treatment modalities can be rapidly developed and brought to market.

Additionally, as regulatory frameworks are evolving to be more accommodating for gene therapy approvals, this opens up avenues for novel therapies to reach patients quicker. Trends in recent times show a marked increase in clinical trials focusing on rare diseases and inherited genetic disorders within South Korea, propelled by advancements in precision medicine.The presence of leading research institutions and universities in the country enhances the innovation landscape, making it an attractive destination for international partnerships.

Furthermore, advancement in technologies such as CRISPR and viral vector development are leading to breakthroughs that could change treatment paradigms. The integration of artificial intelligence in gene therapy research is also becoming a focal point, helping to streamline processes and improve outcomes, indicating a future where personalized medicine is within reach for many more patients in South Korea.

Market Segment Insights

South Korea Gene Therapy Market Segment Insights

Gene Therapy Market Therapeutic Area Insights

The South Korea Gene Therapy Market, particularly within the Therapeutic Area segment, showcases a rapidly evolving landscape driven by advancements in biomedicine and technological innovations. With a growing focus on precision medicine, gene therapy presents a promising avenue for treatment within various therapeutic applications, primarily in Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular Diseases, and Neurological Disorders.

Oncology occupies a significant space in this market due to the increasing incidence of various cancers, pushing continuous demand for targeted therapies that can effectively address specific genetic mutations associated with tumors. Genetic Disorders also represent a crucial area, as gene therapy holds the potential to rectify hereditary conditions by correcting genetic defects at their source, greatly improving patient quality of life.

Infectious Diseases continue to gain attention as researchers explore gene therapy's capabilities in developing vaccines and treatments, particularly in response to emerging viral outbreaks. Similarly, Cardiovascular Diseases are increasingly seen as a major target due to the prevalence of conditions linked to genetic predispositions, thereby creating opportunities for innovative therapeutic methods aimed at repairing or replacing damaged cardiac tissues. Neurological Disorders present another challenging domain where gene therapy could bring breakthroughs in treating complex conditions such as Alzheimer’s disease, Parkinson's disease, and spinal muscular atrophy.

The therapeutic potential in these areas is underscored by ongoing Research and Development initiatives, fostered by supportive governmental policies in South Korea that encourage biomedical innovation and streamline regulatory processes for introducing new therapies into the market. This confluence of demand, innovation, and supportive infrastructure positions the South Korea Gene Therapy Market as a growing force in the healthcare industry, with substantial investment opportunities aligned with unmet medical needs across these critical therapeutic areas.

Gene Therapy Market Technology Insights

The Technology segment of the South Korea Gene Therapy Market plays a crucial role in shaping the landscape of modern therapeutics. With significant focus on advanced modalities such as Viral Vectors, CRISPR, Gene Editing, RNA Therapy, and Non-Viral Methods, this segment has become a cornerstone for innovation and development in gene therapy. Viral Vectors are widely recognized for their effectiveness in delivering therapeutic genes into target cells, making them essential for successful treatment outcomes.

Similarly, CRISPR technology has revolutionized the field by providing precise gene editing capabilities, enabling researchers to manipulate genetic material with unprecedented accuracy.The Gene Editing technology category is rapidly evolving, supporting the development of new therapies for genetic disorders. RNA Therapy has gained traction due to its potential in treating a wide range of diseases by modulating gene expression, while Non-Viral Methods are increasingly popular for their safety and efficiency, allowing for innovative approaches to gene delivery.

Collectively, these technologies drive the South Korea Gene Therapy Market forward, addressing various unmet medical needs and paving the way for future advancements in personalized medicine and therapeutic interventions.As the market continues to grow, investments in Research and Development are vital to overcoming challenges and harnessing the full potential of these transformative technologies.

Gene Therapy Market Application Insights

The South Korea Gene Therapy Market has witnessed significant growth in its Application segment, encompassing Research, Clinical, and Commercial areas. The nation has positioned itself as a leader in biotechnology, supported by strong government initiatives such as the "K-Bio" strategy, which promotes innovative research and development in gene therapy. The Research aspect is crucial as it drives the discovery and development of novel therapeutic techniques, addressing genetic disorders and advancing personalized medicine.

The Clinical application is imperative for translating innovative research findings into practical treatments, with numerous ongoing clinical trials focusing on a wide range of diseases, highlighting its importance in healthcare delivery.In the Commercial domain, gene therapies are becoming increasingly accessible to patients, opened by various partnerships and collaborations between biopharmaceutical companies and research institutions.

This dynamic encourages more investments, accelerates market growth, and enhances patient outcomes, making the Application segment a pivotal factor in the overall landscape of the South Korea Gene Therapy Market. As such, continuous innovations and collaborations are likely to sustain the momentum of growth in this segment.

Gene Therapy Market Route of Administration Insights

The South Korea Gene Therapy Market exhibits a diverse range of delivery mechanisms under the Route of Administration segment, which significantly influences treatment effectiveness and patient compliance. Intravenous administration is crucial due to its rapid systemic distribution, making it an essential method for treating various genetic disorders. Intramuscular routes receive attention for their ease of administration and potential for self-administration, which broadens accessibility for patients. Intradermal methods show promise for localized treatments, particularly for skin-related genetic issues, while intrathecal delivery is critical for targeting central nervous system disorders, ensuring that therapeutic agents effectively reach specific neural tissues.

Oral administration's versatility and potential for patient comfort make it an appealing choice, possibly enhancing adherence to treatment protocols. The combination of these various routes highlights the market's adaptability and responsiveness to patient needs within South Korea, driven by advances in technology and evolving healthcare policies that aim to improve patient outcomes and drive market growth. As the healthcare landscape continues to adapt, these routes play a significant role in shaping the development and delivery of innovative gene therapies, reflecting both market trends and unique regional healthcare dynamics.

Get more detailed insights about South Korea Gene Therapy Market Research Report - Forecast to 2035

Request Free Sample

Key Players and Competitive Insights

The South Korea Gene Therapy Market is witnessing a dynamic and competitive landscape characterized by rapid advancements in technology, increasing investments in research and development, and a growing focus on personalized medicine. The market reflects a strong emphasis on innovative therapies aimed at treating genetic disorders, cancers, and rare diseases. Several players are leveraging breakthrough technologies, including CRISPR and AAV vectors, to develop novel gene therapies that promise improved outcomes. The regulatory environment in South Korea is also evolving to support the development and commercialization of gene therapies, which is enhancing the competitive atmosphere.

As a result, companies are now focusing on collaboration, partnerships, and strategic alliances to capitalize on emerging opportunities and navigate challenges inherent in the development of gene therapeutics.Amgen has established a strong presence in the South Korea Gene Therapy Market, driven by its innovative research portfolio focusing on advanced therapeutic solutions. The company has emphasized the integration of biotechnology with gene therapy principles that align with the region's healthcare needs. Amgen’s strengths lie in its robust pipeline of treatment candidates targeting various genetic conditions and diseases, along with its commitment to precision medicine.

The company has invested significantly in local collaborations that enhance its operational capabilities and market reach, demonstrating its dedication to the South Korean market.

This emphasis on partnerships not only accelerates the development of potential therapies but also enhances patient accessibility to innovative treatments, thereby strengthening Amgen's brand and market position in South Korea.Genethon is a prominent player within the South Korea Gene Therapy Market, recognized for its contributions to the development of therapies aimed at rare genetic disorders. The company focuses on advanced gene therapy techniques, leveraging its expertise to create effective treatment options. Genethon has established strategic alliances with local academic and healthcare institutions, facilitating knowledge exchange and research collaboration that is crucial for accelerating therapy development.

The company is known for its leading products and research initiatives, making significant strides in the commercialization of gene therapies targeted for various conditions prevalent within South Korea. Genethon's commitment to innovation is further highlighted through key mergers and acquisitions that bolster its R&D capabilities, enhancing its ability to deliver cutting-edge therapies that meet the unique healthcare needs of the South Korean population.

Key Companies in the South Korea Gene Therapy Market market include

Industry Developments

The South Korea Gene Therapy Market has witnessed significant developments recently, with Amgen and GSK focusing on expanding their presence through enhanced research initiatives. In October 2023, Samsung Biologics announced a substantial investment aimed at increasing its manufacturing capabilities for gene therapy products, reflecting the growing demand in the region. There has been a notable rise in the market valuation of companies such as LG Chem and BristolMyers Squibb, driven by their advancements in gene editing techniques and successful clinical trials.

In terms of mergers and acquisitions, Genzyme acquired notable gene therapy assets from Sangamo Therapeutics in September 2023, further consolidating its position in the market.

Recent statistics indicate that South Korea's government is prioritizing biopharmaceuticals as a key growth sector, pledging additional support for Research and Development projects. Over the last two to three years, the gene therapy landscape has gained heightened attention, with regulatory approvals accelerating for therapies addressing rare diseases. The increased collaboration among major players like Roche and Novartis has also stimulated innovation, promoting South Korea as a vital hub for gene therapy research and development in the Asia-Pacific region.

Market Segmentation

Outlook

Intravenous
Intramuscular
Intradermal
Intrathecal
Oral

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	129.0(USD Million)
MARKET SIZE 2024	145.4(USD Million)
MARKET SIZE 2035	612.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	13.958% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2023
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Amgen, Genethon, Bluebird Bio, BristolMyers Squibb, Sangamo Therapeutics, Genzyme, Samsung Biologics, Roche, GSK, Medgene, Spark Therapeutics, Hana Biosciences, LG Chem, Novartis, AbbVie
SEGMENTS COVERED	Therapeutic Area, Technology, Application, Route of Administration
KEY MARKET OPPORTUNITIES	Innovative treatment for rare diseases, Expanding regulatory support and incentives, Growing public-private partnerships, Increasing patient awareness and access, Advancements in CRISPR technology
KEY MARKET DYNAMICS	Regulatory support, Increasing R&D investments, Rising incidence of genetic disorders, Expanding healthcare infrastructure, Growing patient awareness
COUNTRIES COVERED	South Korea

FAQs

What is the expected market size of the South Korea Gene Therapy Market in 2024?

The South Korea Gene Therapy Market is expected to be valued at 145.4 million USD in 2024.

What is the projected market size for the South Korea Gene Therapy Market by 2035?

By 2035, the South Korea Gene Therapy Market is projected to reach 612.0 million USD.

What is the expected CAGR for the South Korea Gene Therapy Market from 2025 to 2035?

The expected CAGR for the South Korea Gene Therapy Market from 2025 to 2035 is 13.958%.

Which therapeutic area is expected to hold the largest market share in 2024?

In 2024, the oncology therapeutic area is expected to hold the largest market share, valued at 42.0 million USD.

What is the market size of genetic disorders within the South Korea Gene Therapy Market in 2024?

The market size for genetic disorders in the South Korea Gene Therapy Market is expected to be 36.2 million USD in 2024.

Who are the major players in the South Korea Gene Therapy Market?

Major players in the market include Amgen, Genethon, Bluebird Bio, Bristol-Myers Squibb, and Sangamo Therapeutics.

What is the expected growth of the infectious diseases therapeutic area in the South Korea Gene Therapy Market by 2035?

By 2035, the infectious diseases therapeutic area is expected to grow to 116.6 million USD.

What is the projected market size for cardiovascular diseases in the South Korea Gene Therapy Market in 2024?

The projected market size for cardiovascular diseases is expected to be 22.3 million USD in 2024.

What key trends are emerging in the South Korea Gene Therapy Market?

Key trends include advancements in gene editing technologies and increasing research investment in therapeutic applications.

How will the neurological disorders segment perform by 2035 in the South Korea Gene Therapy Market?

The neurological disorders segment is projected to reach 85.8 million USD by 2035.

South Korea Gene Therapy Market Research Report - Forecast to 2035 Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027